All Resources

Economic Impact • June 12, 2025

Open Letter

Learn more | View

Access to Medicine • March 10, 2025

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget…

Learn more | View

Private Drug Coverage • November 04, 2024

Issues and Opportunities to Modernize Private Drug Plan Sustainability 2024

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • January 04, 2024

IMC Response to the PMPRB’s 2023 Scoping Paper for the Consultations on the Board’s Guidelines

Learn more | View

Access to Medicine • October 19, 2023

Cost Drivers Report 2023

Learn more | View

Private Drug Coverage • September 15, 2023

Cost of A Private Drug Plan Claim

Learn more | View

September 08, 2023

Submission on Consultation regarding Patent Term Adjustment (PTA) Regulations

Learn more | View

Access to Medicine • August 21, 2023

pCPA Temporary Access Process: Innovative Medicines Industry Consultation Response

Learn more | View

Pharmacare • June 01, 2023

Addendum to Innovative Medicines Canada Submission on National Pharmacare

Learn more | View

Access to Medicine • May 16, 2023

Developing a Canadian managed entry approach for new innovation: What can Canada learn from Europe?

Learn more | View

Access to Medicine • May 02, 2023

Clinical Trials in Canada

Learn more | View

Access to Medicine • February 15, 2023

Increasing Access to Innovative Medicines

Learn more | View